The salvage role of allogeneic hematopoietic stem-cell transplantation in relapsed/refractory diffuse large B cell lymphoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
The salvage role of allogeneic hematopoietic stem-cell transplantation in relapsed/refractory diffuse large B cell lymphoma ; volume:13 ; number:1 ; day:15 ; month:10 ; year:2023 ; pages:1-11 ; date:12.2023
Scientific reports ; 13, Heft 1 (15.10.2023), 1-11, 12.2023
- Urheber
-
Min, Gi-June
Jeon, Young-Woo
Kim, Tong Yoon
Kwag, Daehun
Kim, Byung-Su
Lee, Joonyeop
Lee, Jong Hyuk
Park, Sung-Soo
Park, Silvia
Yoon, Jae-Ho
Lee, Sung-Eun
Cho, Byung-Sik
Eom, Ki-Seong
Kim, Yoo-Jin
Lee, Seok
Kim, Hee-Je
Min, Chang-Ki
Lee, Jong Wook
Cho, Seok-Goo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-44241-0
- URN
-
urn:nbn:de:101:1-2024020710413175488123
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Min, Gi-June
- Jeon, Young-Woo
- Kim, Tong Yoon
- Kwag, Daehun
- Kim, Byung-Su
- Lee, Joonyeop
- Lee, Jong Hyuk
- Park, Sung-Soo
- Park, Silvia
- Yoon, Jae-Ho
- Lee, Sung-Eun
- Cho, Byung-Sik
- Eom, Ki-Seong
- Kim, Yoo-Jin
- Lee, Seok
- Kim, Hee-Je
- Min, Chang-Ki
- Lee, Jong Wook
- Cho, Seok-Goo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Management of relapsed-refractory diffuse large B cell lymphoma
Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma
BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience
Consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: who? When? Why?
Alemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma: a single-center analysis
Phase I study of safety and efficacy of allogeneic natural killer cell therapy in relapsed/refractory neuroblastomas post autologous hematopoietic stem cell transplantation
Enhanced platelet function through CAR-T cell therapy in relapsed/refractory multiple myeloma
Single-cell transcriptomic and spatial analysis reveal the immunosuppressive microenvironment in relapsed/refractory angioimmunoblastic T-cell lymphoma
Secondary donor-derived humanized CD19-modified CAR-T cells induce remission in relapsed/refractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Management of relapsed-refractory diffuse large B cell lymphoma
Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma
BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience
Consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: who? When? Why?
Alemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma: a single-center analysis
Phase I study of safety and efficacy of allogeneic natural killer cell therapy in relapsed/refractory neuroblastomas post autologous hematopoietic stem cell transplantation
Enhanced platelet function through CAR-T cell therapy in relapsed/refractory multiple myeloma
Single-cell transcriptomic and spatial analysis reveal the immunosuppressive microenvironment in relapsed/refractory angioimmunoblastic T-cell lymphoma
Secondary donor-derived humanized CD19-modified CAR-T cells induce remission in relapsed/refractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Management of relapsed-refractory diffuse large B cell lymphoma
Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma
BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience
Consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: who? When? Why?
Alemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma: a single-center analysis
Phase I study of safety and efficacy of allogeneic natural killer cell therapy in relapsed/refractory neuroblastomas post autologous hematopoietic stem cell transplantation
Enhanced platelet function through CAR-T cell therapy in relapsed/refractory multiple myeloma
Single-cell transcriptomic and spatial analysis reveal the immunosuppressive microenvironment in relapsed/refractory angioimmunoblastic T-cell lymphoma
Secondary donor-derived humanized CD19-modified CAR-T cells induce remission in relapsed/refractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia